Fatal angioedema induced by angiotensin conversion enzyme (ACE) inhibitors

M. Tiemensma, E. H. Burger, J. J. Dempers, S. A. Wadee

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

ACE inhibitors are often prescribed in the treatment of hypertension, heart failure and kidney disease. These drugs are on the Essential Drugs List, and are therefore used at primary to tertiary health care levels in South Africa. Angioedema is considered a rare, but potentially fatal side-effect of this agent, with a reported incidence of 0.1-0.2% worldwide.1 Its incidence in the South African population is, however, unknown.

Original languageEnglish
Pages (from-to)217-218
Number of pages2
JournalSouth African Family Practice
Volume52
Issue number3
DOIs
Publication statusPublished - 2010
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Fatal angioedema induced by angiotensin conversion enzyme (ACE) inhibitors'. Together they form a unique fingerprint.

Cite this